Survival Analysis on HPV+ OPC patients 55-patient (test)
1.61Log-rank p-valueC3
Evaluation results
| Method | Links | |
|---|---|---|
| C3description=Clinician 32026.04 | 1.61 | |
| C1description=Clinician 12026.04 | 1.76 | |
| C1description=Clinician 12026.04 | 1.82 | |
| C2description=Clinician 22026.04 | 1.86 | |
| SRdescription=Single reader simulated by randomly selecting one of the three annotations per patient and bootstrapping 10,000 times2026.04 | 1.93 | |
| Cdescription=Collegial decision involved a three way consensus2026.04 | 1.98 | |
| C1description=Clinician 12026.04 | 2.16 | |
| Cdescription=Collegial decision involved a three way consensus2026.04 | 2.34 | |
| Cdescription=Collegial decision involved a three way consensus2026.04 | 2.62 | |
| SRdescription=Single reader simulated by randomly selecting one of the three annotations per patient and bootstrapping 10,000 times2026.04 | 2.82 | |
| AMO-ENElabel_in_table=Proposed2026.04 | 2.9 | |
| C2description=Clinician 22026.04 | 3.03 | |
| C2description=Clinician 22026.04 | 3.13 | |
| AMO-ENElabel_in_table=Proposed2026.04 | 3.3 | |
| C3description=Clinician 32026.04 | 3.32 | |
| C3description=Clinician 32026.04 | 3.39 | |
| SRdescription=Single reader simulated by randomly selecting one of the three annotations per patient and bootstrapping 10,000 times2026.04 | 7.78 | |
| AMO-ENElabel_in_table=Proposed2026.04 | 8.02 |